Delivery Order SPE2DB22D1017-SPE2DB25FG5UN
Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Forteo 560 MCG/2.24 ML pen injections valued at $7,333.28. This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was not made under any small business set-aside program and was competitively awarded. Forteo is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections on May 27, 2025, with completion expected by May 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and related bone disorders,...
- The Defense Logistics Agency awarded a $13,965.22 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,246.43 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This competitively awarded, firm fixed-price delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Forteo is a prescription medication used primarily for osteoporosis treatment, reflecting the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,758.08 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed price delivery order was awarded competitively on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used in the treatment of osteoporosis and bone-related...
- The Defense Logistics Agency awarded a delivery order valued at $3,666.64 to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Forteo is a bone-building medication used to treat osteoporosis in patients at high risk of...
- The Defense Logistics Agency awarded a delivery order valued at $13,007.15 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed price contract. The award was made on July 10, 2025, with an ultimate completion date of July 11, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania location. This is a non-set-aside contract awarded through competitive procurement, reflecting the contractor's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injection) valued at $4,239.43 with a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...